Pope Francis’ health remains a “complex” situation, and doctors are modifying the drug regimen they’re using to treat his respiratory tract infection while keeping the 88-year-old pontiff hospitalized ...

Four papers published in JAMA, JAMA Neurology and JAMA Network Open look at Amyotrophic Lateral Sclerosis (ALS) treatment results from the HEALY ALS Platform Trial. Dr Ahmad Al Khleifat, Senior ...

With its recent data drop for an oligonucleotide candidate, Dyne Therapeutics signals it may become a frontrunner in this ...

A biotech company is attempting to persuade Kansas legislators to modify the state’s controlled substances act in advance of ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

has approved a New Drug Application (NDA) for an Evrysdi® (risdiplam) tablet for people living with spinal muscular atrophy ...

The adjusted likelihood for an injurious fall in adults with COPD was elevated with a fall-risk increasing drug prescription, ...

Children's Hospital Colorado is modifying their model of care for providing what they call "puberty blockers and other hormone-based gender-affirming care treatments." ...

Deploying its highly advanced Magellan™ platform, Gain is accelerating drug discovery and unlocking novel disease-modifying ...

The Drug Enforcement Administration ("DEA") announced three new regulations related to the prescription of controlled substances resulting from ...

MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies ...